Vaccines Industry Overview

Portland, OR -- (SBWire) -- 08/01/2017 --Global Vaccines Market is expected to grow at a CAGR of 9.8% from 2017 to 2025. Vaccines are the products that provide acquired immunity against a particular disease. Vaccines consist of killed or modified microbes, parts of microbes, or microbial DNA that make the body think that an infection has occurred. A vaccinated persons immune system attacks the harmless vaccine and prepares the body to be immune against the kind of microbe the vaccine contained.

Continue to Report Description and Full ToC: https://www.progressivemarkets.com/industry-research/vaccines-market

Vaccines Market is divided based on product as conjugate vaccines, toxoid vaccines, recombinant vaccines, live attenuated vaccines, and inactivated & subunit vaccines. Based on type, the vaccines market is segmented as monovalent vaccines, and multivalent vaccines. According to application, the market is divided into polio, Measles, Mumps, and Rubella (MMR), Diphtheria, Pertussis, and Tetanus (DTP), hepatitis, pneumococcal disease, influenza, rotavirus, varicella, meningococcal disease, Human Papilloma Virus (HPV) infection, and others. Geographically, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Vaccines Market Dynamics:

Drivers:
Increase in funding from government and private organizations for R&D of new vaccines.
Increase in incidence of diseases worldwide.
Increase in use of pediatric vaccines.

Restraints:
High capital investment for the development of vaccines.
Stringent governmental rules for approval of vaccines.
Vaccines Market Players:

The top players in the global vaccines market include Astellas Pharma Inc., Emergent BioSolutions, Inc., CSL Limited, GlaxoSmithKline, plc., Johnson & Johnson Pvt. Ltd., MedImmune, LLC, Merck & Co., Pfizer, Inc., Serum Institute of India Pvt. Ltd., and Sanofi Pasteur. Market players for global vaccines market adopt different strategies such as product development, product approval, acquisition, and collaboration to keep pace with the evolving market trends.

Inquire About Report: https://www.progressivemarkets.com/enquiry-about-report/vaccines-market

MARKET LANDSCAPE

By Product
Conjugate Vaccines
Toxoid Vaccines
Recombinant Vaccines
Live Attenuated Vaccines
Inactivated and Subunit Vaccines

By Type
Monovalent vaccines
Multivalent vaccines

By Application
Polio
Measles, Mumps, and Rubella (MMR)
Diphtheria, Pertussis, and Tetanus (DTP)
Hepatitis
Pneumococcal Disease
Influenza
Rotavirus
Varicella
Meningococcal Disease
Human Papilloma Virus (HPV) infection
Others

By Geography
- North America
- Europe
- Asia-Pacific
- LAMEA

Customized Report: https://www.progressivemarkets.com/request-customization/vaccines-market

Table of Content for Vaccines Market

1. Executive summary
1.1. Key findings
1.2. Market attractiveness and trend analysis
1.3. Competitive landscape and recent industry development analysis

2. Introduction
2.1. Report description
2.2. Scope and definitions
2.3. Research methodology

3. Market landscape
3.1. Growth drivers
3.1.1. Impact analysis
3.2. Restrains and challenges
3.2.1. Impact analysis
3.3. Porter's analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. Global vaccines market shares analysis, 2014-2025
3.4.1. Global vaccines market share by product, 2014-2025

Continued…

List of Tables
Contain 48 Tables

List of Figures
Contain 56 Figures

Discount on Full Report: https://www.progressivemarkets.com/get-discount/vaccines-market